You
FiltersClear all
Kind

Style

Leads with

Best for

Industry

Origin

Era · first seen
Uses first seen. Date created is rarely published.
Length

50 closest statements

by meaning · ranked by similarity · 100 per page

Meaning search returns the 50 nearest statements, then applies your filters.

ET
Electromedical Technologies, IncCompany · Health · AZ
Real
“Our mission is to improve global wellness for people suffering from various painful conditions by relieving chronic and acute pain using energy, frequency, and vibration as an alternative to pharmaceuticals and that one day, read and modify electrical signals passing along nerves in the body, to restore long-term health.”
MissionProblem–solutionLeads with problemClimate & health
In use 2024 – now·1 sighting·SEC Form 10-K, filed 2024-05-0158% match
EQ
EQRx, Inc.Company · Health · MA
Real
“Our mission is to improve health for all with great, innovative, affordable medicines so that people with life-changing or chronic conditions can gain access to the medicines they need, physicians can treat patients without barriers to prescribing, and health systems can afford to make those medicines available, without restrictions, to the populations they serve in a financially sustainable manner.”
MissionDemocratizationLeads with accessMission-driven
In use 2022 – now·1 sighting·SEC Form 10-K, filed 2022-03-2358% match
HB
Hoverink Biotechnologies, Inc.Company · Health · CA
Real
“Our mission is to improve the lives of patients who suffer from rare diseases for which there are limited or no available treatments, with an initial therapeutic focus on Cirrhosis ascites, patients suffering from AIDS, Cancer and chronic pain, nausea and discomfort associated with chemotherapy and neuropathy.”
MissionImpactLeads with changeMission-driven
In use 2017 – now·1 sighting·SEC Form 10-K, filed 2017-11-0657% match
FT
Filana Therapeutics, Inc.Company · Health · TX
Real
“Our mission is to develop transformative medicines to improve the lives of patients with central nervous system (CNS) disorders, such as Tuberous Sclerosis Complex (TSC)-related epilepsy and other diseases associated with dysregulation or overexpression of filamin A. Our science is based on modulating the activity of a critical protein in the brain for patients with certain CNS disorders, such as TSC.”
MissionImpactLeads with changeMission-driven
In use 2026 – now·1 sighting·SEC Form 10-K, filed 2026-03-1257% match
Showing 1–50 of 50
0 to compareCompare